Showing results (91-100 of 169) with videos related to
Sort By:
Pageof 17
Ebiomedicine|February 22, 2020
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd Ismail Hosen, Mahdi Sheikh, Maria Zvereva, et al.Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.Scientific Reports|August 5, 2016
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization studyRobert Carreras-Torres, Philip C Haycock, Caroline L Relton, et al.Carcinogenesis|June 21, 2018
Genome-wide association study of familial lung cancerJinyoung Byun, Ann G Schwartz, Christine Lusk, et al.Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.American Journal of Hematology|January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome studyCharles Dumontet, Delphine Demangel, Perrine Galia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.International Journal of Cancer|July 13, 2017
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortiaFangyi Gu, Han Zhang, Paula L Hyland, et al.Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.HGG Advances|January 14, 2026
Germline HLA heterozygosity is associated with decreased lung cancer riskTaotao Tan, Vikram R Shaw, Jinyoung Byun, et al.Pageof 17